Showing results (91-100 of 153) with videos related to
Sort By:
Pageof 16
Biometrics|March 2, 2005
Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twinsStuart G Baker, Paul Lichtenstein, Jaakko Kaprio, et al.Trials|October 7, 2006
Selecting patients for randomized trials: a systematic approach based on risk groupAndrew J Vickers, Barry S Kramer, Stuart G BakerThe International Journal of Biostatistics|April 14, 2012
Evaluating a new marker for risk prediction using the test tradeoff: an updateStuart G Baker, Ben Van Calster, Ewout W SteyerbergBiometrics|August 16, 2011
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific timeStuart G Baker, Daniel J Sargent, Marc Buyse, et al.Journal of Clinical Epidemiology|September 2, 2024
Surrogate endpoint metaregression: useful statistics for regulators and trialistsStuart G Baker, Marissa N D Lassere, Wang Pok LoAnnals of Internal Medicine|September 10, 2014
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 populationPaul F Pinsky, David S Gierada, William Hocking, et al.Pregnancy Hypertension|November 8, 2025
Minimum test tradeoff applied to uterine artery pulsatility index for antepartum prediction of preeclampsiaZachary M Janik, Stuart G Baker, Mellany Stanislaus, et al.Clinical Trials (London, England)|June 24, 2010
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Blacka, Barnett S Kramer, et al.The Lancet. Oncology|March 25, 2016
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trialEdward F Patz, Erin Greco, Constantine Gatsonis, et al.Addiction (Abingdon, England)|October 17, 2009
A common standard for conflict of interest disclosure in addiction journalsMerrill Goozner, Arthur Caplan, Jonathan Moreno, et al.Pageof 16